Anthracycline derivatives having cytostatic activity
US4965352A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 12, 1989 |
| Grant date | Oct 23, 1990 |
| Priority date | — |
| Expiry date | Jun 12, 2009 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to new anthracycline derivatives having cytostatic activity and the general formula I ##STR1## wherein R.sup.1 is a CH.sub.3 (CH.sub.2).sub.n group with n=0 to 3, PA0 R.sup.2 is a hydrogen atom or a methyl group, PA0 R.sup.3 is a hydrogen atom, a methyl group or an acyl protective group, and PA0 R.sup.4 is a hydrogen atom or an acyl protective group, and which are optionally in the form of a salt of an inorganic or organic acid, to a process for their preparation and to their use in pharmaceuticals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.